
@article{ WOS:000906390900003,
Author = {Wang, Xiaohu and Tang, Jin and Shen, Chaozhuang and Wang, Xingwen and
   Hu, Hua and Xie, Haitang},
Title = {Research Progress of Population Pharmacokinetic of Metformin},
Journal = {BIOMED RESEARCH INTERNATIONAL},
Year = {2022},
Volume = {2022},
Month = {DEC 19},
Abstract = {Metformin is commonly used as first-line treatment for T2DM (type2
   diabetes mellitus). Owing to the high pharmacokinetic (PK) variability,
   several population pharmacokinetic (PPK) models have been developed for
   metformin to explore potential covariates that affect its
   pharmacokinetic variation. This comprehensive review summarized the
   published PPK studies of metformin, aimed to summarize PPK models of
   metformin. Most studies described metformin pharmacokinetics as a
   2-compartment (2-CMT) model with 4 study describing its pharmacokinetics
   as 1-compartment (1-CMT). Studies on metformin PPK have shown that
   obesity, creatinine clearance (CLCr), gene polymorphism, degree of renal
   function damage, and pathological conditions all have a certain impact
   on the PK parameters of metformin. It is particularly important to
   formulate individualized dosing regimens. For future PPK studies of
   metformin, we believe that more attention should be paid to special
   populations.},
Publisher = {HINDAWI LTD},
Address = {ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND},
Type = {Review},
Language = {English},
Affiliation = {Hu, H; Xie, HT (Corresponding Author), Yijishan Hosp, Wannan Med Coll, Anhui Prov Ctr Drug Clin Evaluat, 2 Zheshan West Rd, Wuhu 241000, Peoples R China.
   Wang, Xiaohu; Shen, Chaozhuang; Hu, Hua; Xie, Haitang, Yijishan Hosp, Wannan Med Coll, Anhui Prov Ctr Drug Clin Evaluat, 2 Zheshan West Rd, Wuhu 241000, Peoples R China.
   Wang, Xiaohu; Tang, Jin; Shen, Chaozhuang; Wang, Xingwen, Wannan Med Coll, 22 Wenchang West Rd, Wuhu 241000, Peoples R China.},
DOI = {10.1155/2022/4071111},
Article-Number = {4071111},
ISSN = {2314-6133},
EISSN = {2314-6141},
Keywords-Plus = {ORGANIC CATION TRANSPORTER-1; GENETIC-VARIANTS; POLYMORPHISMS;
   PHARMACODYNAMICS; INVOLVEMENT; PREGNANCY; MATE1; OBESE; OCT1},
Research-Areas = {Biotechnology \& Applied Microbiology; Research \& Experimental Medicine},
Web-of-Science-Categories  = {Biotechnology \& Applied Microbiology; Medicine, Research \&
   Experimental},
Author-Email = {wangxiaohu0845@163.com
   1275318942@qq.com
   1174887705@qq.com
   2638471631@qq.com
   115906005@qq.com
   xiehaitang@sina.com},
Affiliations = {Wannan Medical College; Wannan Medical College},
ResearcherID-Numbers = {Zhang, Yuting/JRW-3937-2023
   },
ORCID-Numbers = {Wang, Xingwen/0000-0001-9386-3208
   Shen, ChaoZhuang/0000-0002-2263-2709
   Wang, Xiaohu/0000-0003-2005-0614
   tang, tang jin/0000-0002-6070-7302
   Hu, Hua/0000-0003-2950-4424},
Funding-Acknowledgement = {``Climbing Peak{''} Training Program for the Innovative Technology team
   of Yijishan Hospital of Wannan Medical College;  {[}KPF2019016]},
Funding-Text = {AcknowledgmentsThis work was supported by ``Climbing Peak{''} Training
   Program for the Innovative Technology team of Yijishan Hospital of
   Wannan Medical College (Grant number KPF2019016).},
Cited-References = {Bardin C, 2012, EUR J CLIN PHARMACOL, V68, P961, DOI 10.1007/s00228-011-1207-0.
   Becker ML, 2010, PHARMACOGENET GENOM, V20, P38, DOI 10.1097/FPC.0b013e328333bb11.
   Ceacareanu AC, 2018, J RES PHARM PRACT, V7, P41, DOI 10.4103/jrpp.JRPP\_17\_53.
   Chae JW, 2012, BRIT J CLIN PHARMACO, V74, P815, DOI 10.1111/j.1365-2125.2012.04260.x.
   Charles B, 2006, THER DRUG MONIT, V28, P67, DOI 10.1097/01.ftd.0000184161.52573.0e.
   Chitnis SD, 2016, CLIN PHARM DRUG DEV, V5, P40, DOI 10.1002/cpdd.191.
   Choi Suein, 2018, Transl Clin Pharmacol, V26, P25, DOI 10.12793/tcp.2018.26.1.25.
   Christensen MMH, 2011, PHARMACOGENET GENOM, V21, P837, DOI 10.1097/FPC.0b013e32834c0010.
   Cook MN, 2007, DIABETIC MED, V24, P350, DOI 10.1111/j.1464-5491.2007.02078.x.
   Dissanayake AM, 2018, PHARMACOL RES PERSPE, V6, DOI 10.1002/prp2.424.
   Dissanayake AM, 2017, KIDNEY INT REP, V2, P705, DOI 10.1016/j.ekir.2017.03.005.
   Donnelly LA, 2020, DIABETES CARE, V43, P2493, DOI 10.2337/dc20-1104.
   Duong JK, 2013, CLIN PHARMACOKINET, V52, P373, DOI 10.1007/s40262-013-0046-9.
   Espnes KA, 2022, BASIC CLIN PHARMACOL, V130, P415, DOI 10.1111/bcpt.13703.
   Goswami S, 2014, CLIN PHARMACOL THER, V96, P370, DOI 10.1038/clpt.2014.109.
   Goyal RK, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.873439.
   Hong Y, 2008, J CLIN PHARMACOL, V48, P696, DOI 10.1177/0091270008316884.
   Hughes RCE, 2006, DIABETIC MED, V23, P323, DOI 10.1111/j.1464-5491.2005.01769.x.
   Jang K, 2016, J CLIN PHARMACOL, V56, P1104, DOI 10.1002/jcph.699.
   Kuan IHS, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246247.
   Lalau JD, 2022, DIABETES OBES METAB, V24, P166, DOI 10.1111/dom.14554.
   Li L, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000023212.
   Liao MZ, 2020, DRUG METAB DISPOS, V48, P264, DOI 10.1124/dmd.119.088435.
   Madiraju AK, 2014, NATURE, V510, P542, DOI 10.1038/nature13270.
   McCreight LJ, 2018, DIABETES OBES METAB, V20, P1593, DOI 10.1111/dom.13264.
   Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808.
   Nakamichi N, 2013, J PHARM SCI-US, V102, P3407, DOI 10.1002/jps.23595.
   Sam WJ, 2017, J CLIN PHARMACOL, V57, P219, DOI 10.1002/jcph.796.
   Sandra L, 2021, BRIT J CLIN PHARMACO, V87, P2089, DOI 10.1111/bcp.14620.
   Santoro AB, 2018, BRIT J CLIN PHARMACO, V84, P987, DOI 10.1111/bcp.13522.
   Saxena M, 2013, MOL BIOL REP, V40, P6271, DOI 10.1007/s11033-013-2739-4.
   Shu Y, 2008, CLIN PHARMACOL THER, V83, P273, DOI 10.1038/sj.clpt.6100275.
   Sinnappah KA, 2020, BRIT J CLIN PHARMACO, V86, P1430, DOI 10.1111/bcp.14244.
   Smith FC, 2016, AM J KIDNEY DIS, V68, P990, DOI 10.1053/j.ajkd.2016.08.017.
   Song IS, 2008, CLIN PHARMACOL THER, V84, P559, DOI 10.1038/clpt.2008.61.
   Stocker SL, 2013, CLIN PHARMACOL THER, V93, P186, DOI 10.1038/clpt.2012.210.
   Sturkenboom MGG, 2021, CLIN PHARMACOKINET, V60, P685, DOI 10.1007/s40262-021-00997-0.
   van Rongen A, 2018, PEDIATR DRUGS, V20, P365, DOI 10.1007/s40272-018-0293-1.
   Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140.
   Wellhagen GJ, 2018, CPT-PHARMACOMET SYST, V7, P331, DOI 10.1002/psp4.12290.
   Yang N, 2022, FRONT PHARMACOL, V13, DOI 10.3389/fphar.2022.838205.
   Yoon H, 2013, AAPS J, V15, P571, DOI 10.1208/s12248-013-9460-z.
   Zeitler P, 2012, NEW ENGL J MED, V366, P2247, DOI 10.1056/NEJMoa1109333.},
Number-of-Cited-References = {43},
Times-Cited = {1},
Usage-Count-Last-180-days = {2},
Usage-Count-Since-2013 = {15},
Journal-ISO = {Biomed Res. Int.},
Doc-Delivery-Number = {7M1BP},
Web-of-Science-Index = {Science Citation Index Expanded (SCI-EXPANDED)},
Unique-ID = {WOS:000906390900003},
OA = {Green Published, gold},
DA = {2024-09-07},
}
